These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 9481820
1. The role of CpG dinucleotides in DNA vaccines. Krieg AM, Yi AK, Schorr J, Davis HL. Trends Microbiol; 1998 Jan; 6(1):23-7. PubMed ID: 9481820 [Abstract] [Full Text] [Related]
2. CpG motifs for optimization of DNA vaccines. Davis HL. Dev Biol (Basel); 2000 Jan; 104():165-9. PubMed ID: 11713816 [Abstract] [Full Text] [Related]
8. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. J Immunol; 1998 Sep 15; 161(6):3042-9. PubMed ID: 9743369 [Abstract] [Full Text] [Related]
9. CpG motifs in bacterial DNA trigger direct B-cell activation. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. Nature; 1995 Apr 06; 374(6522):546-9. PubMed ID: 7700380 [Abstract] [Full Text] [Related]
10. Immunostimulatory DNA as a vaccine adjuvant. Higgins D, Marshall JD, Traquina P, Van Nest G, Livingston BD. Expert Rev Vaccines; 2007 Oct 06; 6(5):747-59. PubMed ID: 17931155 [Abstract] [Full Text] [Related]
12. Contribution of CpG motifs to the immunogenicity of DNA vaccines. Klinman DM, Yamshchikov G, Ishigatsubo Y. J Immunol; 1997 Apr 15; 158(8):3635-9. PubMed ID: 9103425 [Abstract] [Full Text] [Related]
13. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. McCluskie MJ, Davis HL. J Immunol; 1998 Nov 01; 161(9):4463-6. PubMed ID: 9794366 [Abstract] [Full Text] [Related]
14. Discovery of immunostimulatory CpG-DNA and its application to tuberculosis vaccine development. Yamamoto S, Yamamoto T, Nojima Y, Umemori K, Phalen S, McMurray DN, Kuramoto E, Iho S, Takauji R, Sato Y, Yamada T, Ohara N, Matsumoto S, Goto Y, Matsuo K, Tokunaga T. Jpn J Infect Dis; 2002 Apr 01; 55(2):37-44. PubMed ID: 12082305 [Abstract] [Full Text] [Related]
15. Adjuvant properties of CpG oligonucleotides in primates. Verthelyi D. Methods Mol Med; 2006 Apr 01; 127():139-58. PubMed ID: 16988453 [Abstract] [Full Text] [Related]
16. The role of CpG motifs in innate immunity. Krieg AM. Curr Opin Immunol; 2000 Feb 01; 12(1):35-43. PubMed ID: 10679406 [Abstract] [Full Text] [Related]
17. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes. Stan AC, Casares S, Brumeanu TD, Klinman DM, Bona CA. Eur J Immunol; 2001 Jan 01; 31(1):301-10. PubMed ID: 11265647 [Abstract] [Full Text] [Related]
19. Local and systemic B cell and Th1 responses induced following ocular mucosal delivery of multiple epitopes of herpes simplex virus type 1 glycoprotein D together with cytosine-phosphate-guanine adjuvant. Nesburn AB, Ramos TV, Zhu X, Asgarzadeh H, Nguyen V, BenMohamed L. Vaccine; 2005 Jan 04; 23(7):873-83. PubMed ID: 15603887 [Abstract] [Full Text] [Related]
20. CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy. Chaung HC. Int Immunopharmacol; 2006 Oct 04; 6(10):1586-96. PubMed ID: 16919831 [Abstract] [Full Text] [Related] Page: [Next] [New Search]